Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA_A receptor is a major inhibitory neurotransmitter receptor in the mammalian central nervous system. It mediates fast synaptic inhibition by functioning as a ligand-gated chloride ion channel, activated primarily by gamma-aminobutyric acid (GABA). It is a pentameric transmembrane protein composed of various subunits, resulting in diverse isoforms with distinct properties. Modulation by various endogenous compounds and drugs such as benzodiazepines, barbiturates and neurosteroids makes it a major drug target.
Binding of GABA or agonists leads to conformational change, opening of the chloride channel, influx of chloride ions, and hyperpolarization of the neuron, resulting in inhibition.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-Aminobutyric Acid Type A Receptor (GABA_A Receptor).